DEA Information for Pharmacists | August 2022

DEA has provided information regarding what a pharmacist can add to a controlled substance prescription:

Title 21 CFR 1306.05(a) states what information is required to be on a prescription when it is prepared by the practitioner, “All prescriptions for controlled substances shall be dated as of, and signed on, the day when issued and shall bear the full name and address of the patient, the drug name, strength, dosage form, quantity prescribed, directions for use, and the name, address and registration number of the practitioner.”

DEA is currently reviewing the relevant regulations found under 21 CFR part 1300 to end, and working to draft regulations to address what, if any, information a pharmacist can add to a prescription. DEA encourages you to monitor the website for any new Notices of Proposed Rulemaking. See also the Office of Management and Budget, Unified Agenda of Regulatory and Deregulatory Actions at for status updates on any pending regulations.